BioNTech went public with a market value of ~$3.5B, solidly into unicorn territory, despite losing a tad over $100m the prior two years. Through the typical business lens, this makes sense as they were in investment phase hoping for a potentially large payoff as their product matured. The IPO gave them the capital they needed to realize their vision.
Obviously, they are worth a lot more now because that narrative was correct. Should they have been more conservative and only expanded R&D at a pace supported by their revenue?
For every Google or Facebook (arguably two of the best business models in history), you can name an Amazon, Netflix, Broadcom, DocuSign, Square, or Tesla. Success comes in different flavors.
(Tesla notably spent something like $10B before getting to profitability. This is an artifact of the intersection of their market and their global ambitions. Unlikely they would have had the impact on major auto manufacturers as a much smaller, profitable, boutique firm.)
I guess this redefines the concept of unicorn, as this is not market valuation but actual profits.